TS03 Inc Trust Units TSTIF

RE:RE:VGH Report Very Positive!

[Drrwong]

Thank you for the link, Echo2.

The link definitely works, but it is interesting as I do not see this listed on the TSO3 website or my Bloomberg terminal yet.  

It is reassuring that VGH is not seeing any additional wear-n-tear from VP4 (actually less issues than HLD), which is the main question FDA seems to be looking at in its information request.

Seems like 1H18 would be huge on a regulatory front for TSO3, as both the FDA decision on extended claims as well as the conlcusion of this VGH trail should be out.  

Finally, for those who are trying to predict Q3 sales (I don't as I view that as too short term for my investing style, but I know some do)--we should keep in mind that TSO3 had $700k USD worth of "finished goods" inventory at the end of Q2, which means roughly 5 VP4s.  So these could be sold on top on the units that are manufactured during the quarter.  Finally, if we look back in 2015 and 2016, we saw a substantial sales ramp between Q2 and Q3 as a seasonal pattern...just a FYI